Carbohydrate antigen detection, nucleic acid probe detection, and bacterial culture are commonly used to confirm group A streptococcus (GAS) pharyngitis. Compared to standard throat swab specimens, the sensitivities of these tests with mouth specimens are poor. When testing for GAS pharyngitis, the throat remains the optimum site for sampling.
swab collection/transport system (COPAN Venturi Transystem; COPAN Diagnostics Inc., Corona, CA). The standard posterior pharyngeal (throat swab) collection technique involved vigorous swab sampling of the posterior pharynx and bilateral tonsillar tissue while avoiding contact with the tongue, buccal surfaces, and lips. The oral cavity (mouth swab) collection technique involved blind sampling of the subject's mouth, targeting the tongue and buccal mucosa. Each subject was asked to rate his/her pain with a validated age-appropriate pain scale after each swab collection (11) .
Immediately after sample collection, one swab from each site was used for direct antigen detection with an Abbott Signify Rapid Strep A test (Abbott Laboratories, Abbott Park, IL). Within 24 h, a nucleic acid probe test (Gen-Probe Direct Strep test; Gen-Probe Inc., San Diego, CA) was performed on the remaining throat and mouth swabs according to the manufacturer's instructions, and a broth-enhanced culture for GAS was performed on the pledget from each collection/transport tube system. Briefly, the pledget was placed into LIM broth (Becton Dickinson, Sparks, MD) and incubated overnight at 35°C. A subculture of the broth was performed on SXT blood agar (Becton Dickinson), and the plate was incubated in 5% CO 2 at 35°C for 48 h. Beta-hemolytic colonies were identified as GAS by a latex agglutination test (Streptex GAS test; Remel Inc., Lexena, KS). The gold standard for diagnosing GAS pharyngitis was a positive culture or nucleic acid probe of the pharyngeal/tonsillar specimens.
It was determined that 58% (31/53) of subjects had GAS pharyngitis. Only one patient had discordant throat probe and culture results. For testing of throat swab specimens, the sensitivity and specificity were 80.6% and 100%, respectively, for the direct antigen test and 93.3% and 95.7%, respectively, for the nucleic acid probe test. For testing of mouth swab specimens, the sensitivity and specificity were 19.4% and 100%, respectively, for the direct antigen test and 41.9% and 100%, respectively, for the probe test. The sensitivity of enhanced culture performed on mouth swab specimens was 80.6% (Table 1) . By pairwise comparison, the sensitivity of tests performed on mouth swabs was lower than the sensitivity of the same tests performed on throat swabs (P Ͻ 0.001, analysis of variance for proportions). The level of subject discomfort during collection of mouth swabs was lower than that during collection of throat swabs (data not shown; P Ͻ 0.0001, Wilcoxon signed rank sum test).
Throat swab sampling demonstrated superior sensitivity for all GAS detection techniques investigated in this study, substantiating the importance of a well-collected sample from the posterior pharynx when attempting to diagnose GAS pharyngitis. The performances of the direct antigen and nucleic acid probe tests on throat swabs in this study were similar to previously reported data (5, 8, 10) . However, the sensitivity of each test (direct antigen, probe, and culture) on mouth swabs was unsatisfactory compared to the recommended throat swab. Notably, the prevalence of GAS pharyngitis in this study population (58%) was higher than that from previously published reports (1) . While the positive and negative predictive values of tests may be affected, prevalence does not affect a test's sensitivity and specificity. Although throat sampling is less tolerable to patients, medical personnel should make every effort to obtain samples from the posterior pharynges and tonsils of children with sore throats.
Despite this recommendation, our data suggest that there may be some utility in special circumstances to performing direct antigen tests on swab specimens believed to arise from nonpharyngeal/nontonsillar sites. One such circumstance involves the uncooperative child for whom a "clean" throat swab without oral secretion contamination is impossible to obtain. With excellent specificity, positive direct antigen tests of such samples-collected inadvertently/purposively from the oral cavity-would be sufficient to confirm GAS pharyngitis. A negative test in this situation, however, would not exclude this infection and should prompt additional attempts to sample the posterior pharynx for further testing, empirical treatment with antibiotics, or performance of an enhanced culture on the remaining mouth swab.
In conclusion, our study validates recommendations by the IDSA to obtain a sample from the posterior pharynges and tonsils of patients suspected of having GAS pharyngitis. Traditional as well as modern tests used to detect the presence of GAS in symptomatic children (direct carbohydrate antigen, DNA probe, and sheep blood agar culture) all perform significantly better on specimens obtained from the throat.
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